Eli Lilly’s (LLY) latest vaccine shopping spree and GeoVax Labs’s (GOVX) sharpened strategic focus together seemingly sketch a quietly bullish subplot in an otherwise noisy biotech market, giving investors a fresh angle on infectious disease and immuno-oncology risk-on exposure.
Big Pharma Goes Vaccine Hunting Again
Eli Lilly is redeploying its GLP‑1 cash machine into infectious disease prevention, agreeing to acquire three vaccine developers—Curevo, LimmaTech Biologics, and Vaccine Company—for up to nearly 4 billion dollars in combined consideration. The move marks a return to the vaccine arena, positioning Lilly to complement its obesity franchise with a portfolio of late‑breaking shots against shingles, bacterial pathogens, and Epstein‑Barr virus at a time when post‑pandemic policy makers are rediscovering the value of preparedness.
What Lilly Is Actually Buying
Curevo brings a shingles vaccine candidate aimed at adults, with shareholders eligible for up to 1.5 billion dollars in cash through an upfront payment plus clinical and commercial milestones. LimmaTech, focused on vaccines against bacterial pathogens, comes in at up to 780 million dollars, again structured as upfront plus success‑based payments that keep Lilly’s checkbook aligned with data. Vaccine Company rounds out the trio with an Epstein‑Barr virus vaccine program valued at up to 1.55 billion dollars, giving Lilly a shot on goal in one of the more underappreciated viral markets.
Why The Street Is Paying Attention
The deals land against the backdrop of Lilly’s surging weight‑loss franchise, which has left the company cash‑rich and increasingly incentivized to further diversify beyond a single gigantic therapeutic pillar. On the news of the acquisitions, Lilly’s shares ticked higher in premarket trading, a modest but telling signal that investors are willing to fund a pivot back into infectious diseases—so long as management keeps the deal sizes under megacap‑busting levels.
Vaccines, Optionality, And The Post‑Pandemic Memory
A trio of targeted vaccines gives Lilly multiple embedded call options on future public‑health priorities, from shingles in aging populations to bacterial resistance and Epstein‑Barr’s complex role in chronic disease. For investors, the acquisitions offer a way to stay exposed to pandemic‑era policy learning—stockpiles, procurement agreements, emergency authorizations—without betting on another global shutdown to make the math work.
GeoVax Tightens Its Focus
While Lilly adds programs, GeoVax is pruning its pipeline, doubling down on two lead assets: GEO‑MVA, a Modified Vaccinia Ankara vaccine targeting mpox and smallpox, and Gedeptin, an oncology program for solid tumors. As part of the realignment, GeoVax elected to discontinue active development of its GEO‑CM04S1 Covid‑19 vaccine candidate, freeing capital and management bandwidth for programs with clearer regulatory and commercial pathways.
GEO‑MVA’s Regulatory ‘Shortcut’
GEO‑MVA is advancing under an expedited regulatory pathway shaped by scientific advice from the European Medicines Agency, opening the door to potential approval based on a single pivotal immunobridging study. By targeting non‑inferiority to an already approved MVA vaccine and leveraging clinical‑grade material that is manufactured and released for use, GeoVax aims to compress timelines and lower development risk while keeping an eye on potential emergency‑use opportunities.
Gedeptin And The Oncology Angle
Alongside GEO‑MVA, GeoVax is advancing Gedeptin, an immuno‑oncology program geared toward solid tumors, with a current focus on head and neck cancers. By concentrating capital on high‑conviction programs, GeoVax is effectively trading a broad but expensive vaccine wishlist for a narrower, potentially more partner‑friendly platform that can plug into larger companies’ oncology and infectious‑disease engines.
From Spray And Pray To Curated Pipelines
Lilly’s deal‑making and GeoVax’s portfolio triage underscore a broader shift in biotech from “spray and pray” pipelines to curated, regulator‑aligned asset stacks. For investors, that means potentially fewer headline‑grabbing moonshots and more methodical, milestone‑weighted structures where capital is released in step with data rather than PowerPoint projections.
How The Market May Reprice Biodefense
The combination of a big‑pharma return to vaccines and a clinical‑stage player pushing mpox/smallpox candidates through an accelerated European framework puts biodefense and outbreak‑ready platforms back on the institutional radar. If regulators continue to reward immunobridging designs and governments lean into stockpiles and advance purchase agreements, the sector could see a multiple‑expansion rerating that rewards platforms capable of rapid manufacturing, higher yields, and lower costs.
Investor Takeaways And Watchpoints
For diversified healthcare investors, Lilly’s acquisitions offer an incrementally positive tilt toward vaccines without meaningfully reshaping the company’s risk profile, especially given the milestone‑heavy structures. GeoVax, by contrast, represents a higher‑beta, development‑stage expression of a similar theme—leaner, more focused, and acutely sensitive to regulatory, financing, and trial‑execution milestones over the next several years.
Learn More at This Tribe CEO Webinar Event On Thursday, May 28
[1] Lilly to acquire three vaccine developers for nearly $4 billion https://finance.yahoo.com/sectors/healthcare/articles/lilly-acquire-three-vaccine-developers-105831332.html [2] GeoVax Accelerates Focus on GEO-MVA Commercialization and … https://www.eqs-news.com/news/corporate/geovax-accelerates-focus-on-geo-mva-commercialization-and-advancement-of-oncology-program-gedeptinr/b739291c-c755-40af-83cc-41419b448bb2_en [3] Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion https://www.bloomberg.com/news/articles/2026-05-26/lilly-to-buy-three-vaccine-developers-for-up-to-3-8-billion [4] Lilly to acquire three vaccine developers for up to $3.83 billion https://www.investing.com/news/company-news/lilly-to-acquire-three-vaccine-developers-for-up-to-383-billion-93CH-4709260 [5] Eli Lilly to buy three small vaccine developers – STAT News https://www.statnews.com/2026/05/26/eli-lilly-acquisitions-vaccine-developers/ [6] Lilly to acquire three vaccine developers for nearly $4-billion https://www.theglobeandmail.com/business/article-eli-lilly-buy-vaccine-developers-curevo-limmatech/ [7] GeoVax Labs, Inc. (GOVX) Latest Press Releases & Corporate News https://finance.yahoo.com/quote/GOVX/press-releases/ [8] GeoVax Advances GEO-MVA Program with Pivotal Phase 3 Study https://www.linkedin.com/posts/geovax-inc-_biotech-vaccines-publichealth-activity-7450543664457723904-PzGV [9] GeoVax Labs, Inc. (NASDAQ: GOVX) – YouTube https://www.youtube.com/watch?v=lTbGVu95Jq0 [10] Lilly Agrees to Buys Trio of Vaccine Developers – WSJ https://www.wsj.com/business/deals/lilly-agrees-to-buys-trio-of-vaccine-developers-cd5d50fa [11] Lilly to acquire three vaccine developers for nearly $4 billion https://x.com/ReutersLegal/status/2059230595423653933 [12] The Wall Street Journal – Breaking News, Business, Financial & Economic News, World News and Video https://www.wsj.com [13] Eli Lilly to buy three small vaccine developers https://x.com/statnews/status/2059240472489361626
Wall Street loves a good fight over pricing power. Now it has one playing out in orbit—right where the future of defense, data, and deal-making is headed.
The War Where Margin Meets Missile
In the Iran war, Starlink has quietly become the nervous system of U.S. drone operations—fielding real‑time targeting data, encrypted comms, and guidance for disposable drones that cost less than a business‑class ticket but can alter the course of a campaign. As the tempo of strikes accelerated, SpaceX reportedly pushed through a steep price hike on Starlink connectivity, turning battlefield bandwidth into a high‑margin line item. For investors, that reads less like a contract dispute and more like an inflection point: the moment satellite internet stopped being a low‑ARPU utility and started trading like wartime software.
What’s really on display is asymmetrical dependence. The Pentagon can swap jet suppliers over a decade; it cannot swap constellations mid‑war. That imbalance is exactly what markets reward—recurring revenue + zero‑substitute product + urgent customer equals the kind of pricing power that usually shows up in investor decks, not in declassified procurement memos.
Starlink Becomes a Defense Asset Class
For years, Starlink was pitched to investors as rural broadband from space, a way to connect cabins, cargo ships, and cruise liners. That story still matters—but it’s becoming the subplot. As militaries discover they can task cheap drones and small units through LEO constellations, Starlink is morphing into something much more investable: a dual‑use defense platform with global footprint, software‑like scalability, and built‑in geopolitical moat.
In practical terms, that means three things investors care about:
New tiers of service: “Aviation‑grade,” “tactical,” and “Starshield”‑style offerings can be priced far above consumer packages, with defense‑level service‑level agreements and margins to match.
Embedded switching costs: Once a combatant’s doctrines, hardware, and training are written around a specific network, churn isn’t a Q4 risk—it’s a strategic impossibility.
Budget resilience: Defense spending, especially on communications and ISR (intelligence, surveillance, reconnaissance), tends to grow through crises, not in spite of them.
In other words, Starlink isn’t just selling bandwidth; it’s selling optionality to governments terrified of being offline in the one moment they can least afford it.
A New Space–Defense Trade Is Forming
For global investors, the Pentagon–SpaceX spat is a flare in the night sky pointing to a broader trade: the convergence of space infrastructure, defense software, and real‑time data as a single sector narrative.
Here’s how the story could spread—and why it’s viral‑worthy:
Space infrastructure becomes the new “rails”: LEO constellations for comms, sensing, and navigation will form the backbone of future conflicts and supply chains. Investors will start grouping these names the way they once grouped railroads or telcos.
Dual‑use is the new moat: Companies that can sell to both militaries and commercial customers—shipping, aviation, energy, disaster response—will enjoy smoother revenue and more political protection.
Conflict‑driven CapEx: Each geopolitical shock (Iran, Red Sea, Taiwan worries) adds another layer of recurring demand for resilient, low‑latency connectivity and targeting data.
As headlines about “the war that made Starlink indispensable” circulate, expect capital to hunt for the next names that can sit at that same intersection of orbit, software, and sovereignty.
The Musk Discount, the War Premium
SpaceX sits in the unusual position of having both a “Musk discount” and a “war premium” at the same time. On one hand, investors worry about key‑person risk and unpredictable public behavior. On the other, governments are discovering that his company operates infrastructure they simply cannot live without in wartime.
When those two forces collide, they create volatility—which is exactly the soil viral market narratives grow in. You don’t need Starlink itself to IPO for this story to move markets: ecosystem names in launch, satellite manufacturing, defense primes, and electronic warfare could all re‑rate as investors extrapolate one high‑stakes pricing fight into a structural trend.
The real kicker for global audiences: this isn’t just about the U.S. and Iran. Every government with an eye on its neighborhood is watching this episode and asking the same question—do we want to be a customer of this infrastructure, a competitor in it, or permanently dependent on someone else’s billionaire for our communications in a crisis?
Investors’ Playbook: What to Watch Next
To turn this from an interesting narrative into an investable one, a few signposts matter:
Contract language: Future defense agreements around space‑based connectivity will reveal how much pricing power private operators can lock in when the shooting starts.
Copycat constellations: If rivals accelerate LEO networks of their own, it will either validate the theme or cap pricing power by adding competition.
Policy backlash: Lawmakers may push for “sovereign space backstops” or diversified providers, but history suggests regulation usually lags dependence, not the other way around.
For now, one thing is clear: the Iran war has made visible a truth markets will not forget—whoever owns the orbital stack doesn’t just sell internet; they rent out destiny, billed monthly, with wartime surcharges.
Do you want a second list that’s trimmed down to only the most quotable, paywall‑light links for easy sharing in a newsletter or post?
Sources [1] Pentagon spars with SpaceX over Starlink price hike during Iran war https://www.reuters.com/business/aerospace-defense/pentagon-spars-with-spacex-over-starlink-price-hike-during-iran-war-2026-05-26/ [2] Iran war saddles global companies with $25 billion bill – and counting https://www.reuters.com/world/europe/iran-war-saddles-global-companies-with-25-billion-bill-counting-2026-05-18/ [3] Reuters: Starlink outage exposed Pentagon’s growing reliance on … https://anews.az/en/world/511659/reuters-starlink-outage-exposed-pentagonrsquos-growing-reliance-on-spacex/ [4] Pentagon concerned over Musk’s satellite network outages – Dawn https://www.dawn.com/news/1992439 [5] U.S. Smuggled Thousands of Starlink Terminals Into Iran After … – WSJ https://www.wsj.com/world/middle-east/u-s-smuggled-thousands-of-starlink-terminals-into-iran-after-protest-crackdown-69a8c74f [6] SpaceX Advance Guard Joins Tech Skirmishes To Protect Starlink In … https://www.forbes.com/sites/kevinholdenplatt/2026/03/25/spacex-advance-guard-joins-tech-skirmishes-to-protect-starlink-in-iran/ [7] Powell era ends, Iran war costs $25B | Reuters World News – YouTube https://www.youtube.com/watch?v=nuyywG-c4V4 [8] Oil prices rise 3% to two-week high on Iran war supply concerns https://www.reuters.com/business/energy/oil-rises-more-than-1-after-drone-attack-uae-nuclear-power-plant-2026-05-17/ [9] It is now basically confirmed that Iran’s security forces – Binance https://www.binance.com/en/square/post/35120114541114 [10] Numbered References – The Writing Center https://writing.wisc.edu/handbook/documentation/docnumreference/ [11] Citing references: Compiling a reference list or bibliography https://libguides.reading.ac.uk/citing-references/compilingbibliography [12] Writing a Paper using Numbered References – YouTube https://www.youtube.com/watch?v=NFJtleptUz4 [13] How to insert a link to your Sources Cited in a Word document https://www.youtube.com/watch?v=zhdp7VpaY6I [14] How To Add Numerical References to Scientific Manuscripts https://www.journal-publishing.com/blog/numerical-references-scientific-manuscripts/ [15] Sample Reference List – Citation Guide https://subjectguides.fortlewis.edu/citations/ieeesreferences [16] Citation Styles Guide | Examples for All Major Styles – Scribbr https://www.scribbr.com/citing-sources/citation-styles/ [17] 7 Tips for Citing Links – Lumivero https://lumivero.com/resources/blog/7-tips-for-citing-links/ [18] Citations & Formatting – Using the Library of Congress Online https://guides.loc.gov/student-resources/citations
Pope Leo XIV’s warning about artificial intelligence and China’s chip ambitions arrived on the same day, sketching a future in which code, conscience and copper producers all compete for the upper hand. It is a world where Rome calls for moralcircuit‑breakers while Huawei Technologies quietly rewrites the rules of chip design, Nvidia Corporation (NASDAQ: NVDA) tests the limits of U.S. export rules, and Freeport‑McMoRan Inc. (NYSE: FCX) supplies the copper that keeps the whole system powered.
Rome’s New AI Sermon
In his first AI‑focused encyclical, Pope Leo XIV warns that artificial intelligence is edging toward an “anti‑human” vision if left to a small group of powerful actors and opaque algorithms. He argues that technology is not inherently hostile to humanity, but that profit‑driven deployment without ethical guardrails risks sidelining workers, hollowing out communities and eroding human dignity.
The document casts AI as a structural force already shaping hiring decisions, access to healthcare, security protocols and what people see online, often via systems that users neither understand nor control. To a readership that includes CEOs, politicians and retail investors alike, the Pope’s message is less “abandon AI” than “govern it before it governs you.” For listed AI beneficiaries like Nvidia (NVDA), which has become a central supplier of AI compute, the subtext is that ethical and regulatory scrutiny will increasingly travel with the stock symbol.
Autonomous Weapons in the Confessional
Nowhere is the Vatican’s concern sharper than in the realm of autonomous weapons, which Pope Leo says are becoming “practically beyond” effective human control. He warns that AI‑driven killing systems risk decoupling lethal force from human judgment, pushing conflict toward a permanent, low‑friction state of algorithmic escalation.
The encyclical calls for strict limits on AI in warfare and insists that humans—not software—remain accountable for every decision to use force. In a nod to policymakers, the Pope urges “robust legal frameworks” and independent oversight to keep militaries and defense contractors from outsourcing moral responsibility to code. For investors, that raises the odds that defense, semiconductor and software names with heavy exposure to military AI will see more questions on earnings calls that sound suspiciously like they were drafted in a theology department.
A Papal Agenda for AI Governance
Beyond weapons, Pope Leo’s AI blueprint reads like a policy investor’s checklist: more government oversight of the companies building frontier systems, stronger worker protections, and serious retraining for those displaced by automation. He presses for education that teaches students to think critically about technology, rather than treat algorithms as oracles, and for safeguards shielding children from violent or hypersexualized AI‑generated content.
The encyclical also targets information asymmetry, warning that advanced AI can turbocharge misinformation, amplify conflict and leave societies stuck in a loop of outrage and risk‑taking. It is, in effect, a call for political leaders to “slow things down when everything is accelerating” and to ensure that entire populations are not left unemployed, unneeded and digitally pacified. For AI‑exposed companies such as Nvidia (NVDA), which increasingly sits at the center of data‑center and model‑training infrastructure, the message is clear: regulation is not a tail risk—it is moving into the base case.
Meanwhile in Shanghai: Huawei Bends the Rules of Scaling
While Rome debates the soul of AI, Shanghai is arguing with Moore’s Law. Huawei Technologies, still privately held and therefore absent from public stock screens, has unveiled a chip‑design framework it says could deliver transistor densities comparable to “1.4‑nanometer‑class” processes within the decade, even without access to extreme ultraviolet lithography tools restricted by U.S. sanctions.
The centerpiece is an architecture dubbed “LogicFolding,” which physically folds and stacks logic circuits into 3D‑like structures to shorten internal wiring, cut signal delays and pack more performance into a given footprint. By focusing on how signals travel through the chip rather than shrinking each individual transistor, Huawei claims gains in transistor density and power efficiency that could rival foreign leaders like Taiwan Semiconductor (TSM) and Nvidia Corporation (NVDA).
From Moore’s Law to the Tau Scaling Law
To justify this design pivot, Huawei is championing a new “Tau Scaling Law,” a theory that prioritizes reducing the time signals take to move through a chip rather than obsessing over ever‑smaller geometries. The shift amounts to telling Moore’s Law to share top billing with latency: instead of simply doubling transistors, the goal is to fold and route logic so that electrons have less real estate to traverse.
Company executives say LogicFolding and the Tau Scaling Law could deliver roughly double‑digit gains in transistor density and power efficiency compared with conventional designs, helping close the gap with advanced nodes manufactured abroad. Huawei plans to roll the architecture into upcoming Kirin smartphone processors—expected to debut in its flagship Mate 90 line—as a commercial testbed for the approach. If it works, the company could reduce reliance on cutting‑edge foreign fabs while still marketing “near‑frontier” performance inside China, a prospect that would indirectly affect listed rivals and suppliers who trade against Huawei’s shadow, from Nvidia (NVDA) in GPUs to copper‑heavy miners like Freeport‑McMoRan (FCX) that serve the broader electronics and infrastructure buildout.
Nvidia, Sanctions and the AI Chip Chessboard
Huawei’s timing is not accidental. Nvidia, whose shares trade on the Nasdaq under ticker NVDA, faces ongoing regulatory hurdles in supplying high‑end AI chips to the Chinese market, leaving a lucrative gap for domestic contenders. By telegraphing a roadmap to 1.4‑nanometer‑class densities and showcasing a three‑year plan for AI chips, Huawei is signaling to Beijing and global investors that it intends to be the default AI silicon provider within China’s walled garden—even if outside investors cannot buy Huawei equity directly.
The broader strategy is to turn U.S. export controls into an innovation forcing function rather than a hard ceiling. If LogicFolding proves viable at scale, Huawei could offer AI accelerators and premium smartphone chips that are “good enough” to anchor domestic ecosystems, even if the absolute performance crown remains with chips fabricated on the most advanced foreign nodes. That would ripple through portfolios holding Nvidia (NVDA) and large copper producers like Freeport‑McMoRan (FCX), whose fortunes ride on long‑cycle demand for data centers, transmission lines and the broader electrification that underpins digital infrastructure.
Copper, Conductivity and Conscience
If AI is the brain and semiconductors are the neurons, then copper is the circulatory system—and Freeport‑McMoRan Inc. (NYSE: FCX) sits near the center of that trade. As a leading copper producer with large mining operations in the Americas and Indonesia, Freeport’s output feeds everything from AI‑heavy data centers and high‑end networking gear to electric‑vehicle wiring and grid upgrades.
The race to build AI infrastructure and next‑generation wireless networks has intensified demand for copper‑intensive projects, even as environmental, social and governance concerns put pressure on miners to improve their practices. In a way, Freeport and its peers mine the physical preconditions for the digital systems that Pope Leo is asking the world to examine more critically. The Vatican’s call for ethical AI and the market’s appetite for AI‑linked metals may eventually collide in boardrooms where executives have to explain not just earnings per share, but also how responsibly those electrons and electrons’ favorite metal are sourced.
When Ethics Meet Edge Nodes
Taken together, the Vatican’s moral critique and Huawei’s engineering gambit show AI’s future being shaped at both the level of principle and of process node. While Pope Leo urges governments to slow down and regulate, Huawei is racing to speed up data through vertically stacked logic blocks, hoping to outrun sanctions and supply‑chain bottlenecks.
For markets, that tension is likely to define the next chapter of AI investing: demand for ever‑more powerful hardware, countered by calls to cap certain uses, especially in autonomous weapons and high‑risk decision systems. In practical terms, investors may soon find themselves reading an AI risk section in annual reports that quotes both transistor densities and papal encyclicals—thermal constraints on one page, ethical constraints on the next, with tickers like NVDA and FCX threading through the footnotes.
SpaceX’s draft IPO filing reads less like a rocket company’s prospectus and more like the business plan for an orbital AI hyperscaler, with Elon Musk effectively pitching investors on “the largest actionable TAM in human history” and a capex bill to match. The result is a rare spectacle even by Silicon Valley standards: a space firm promising $28.5 trillion of opportunity, burning cash at AI-giant levels, and still asking the public markets for what could be a record-breaking valuation.
A Trillion-Dollar Launchpad
SpaceX is preparing what may become the largest IPO on record, with reports flagging a potential valuation of around 1.75 trillion dollars and a planned capital raise in the neighborhood of 75 billion dollars. At that scale, the company would debut bigger than some of today’s marquee blue chips, effectively asking public investors to price it as both an infrastructure utility for space and a top-tier AI platform.
The filing follows a decade-plus of private-market appreciation that saw SpaceX reach an estimated 800 billion dollar valuation in late 2025, helped along by secondary share sales and a steady stream of institutional demand. The IPO, in other words, is less an introduction than a coming-out party for a company that has already been treated as a quasi-public bellwether for both commercial space and next-generation networks.
The $28.5 Trillion PowerPoint
Right up front, SpaceX opens its prospectus with a chart that could have been storyboarded in a late-night strategy session at a consulting firm: a total addressable market of 28.5 trillion dollars, sliced neatly into AI, connectivity, and space. Of that total, a staggering 26.5 trillion dollars is attributed to AI, leaving 1.6 trillion dollars for connectivity and a relatively modest 370 billion dollars for what most people still think of when they hear “SpaceX”: rockets and orbital hardware.
The message is unmistakable: investors may be buying into rockets and satellites, but the real pitch is that SpaceX intends to become one of the dominant platforms for AI workloads, especially those that demand massive compute and global coverage. The space business, in this framing, becomes the supporting cast—vital, capital intensive, and strategically important, but ultimately there to enable an AI-centric revenue engine.
Spending Like an AI Giant
If the charts are bold, the spending is bolder. SpaceX’s capital expenditures climbed from about 4 billion dollars in 2023 to 11 billion dollars in 2024, with projections of 20 billion dollars in 2025. Annualizing the first quarter of 2026, the company’s capex run rate approaches 40 billion dollars, essentially doubling year over year and firmly placing the firm in the same spending league as the largest AI and cloud providers.
Much of that surge is coming from AI-related investments, particularly after SpaceX absorbed xAI, Musk’s AI venture, in early 2026. AI capex reportedly grew from hundreds of millions in 2023 to over 12 billion dollars by 2025, with filings suggesting that AI will make up the majority of SpaceX’s capital spending in the current year.
Starlink: The Cash-Flowing Satellite
Underneath the AI fanfare, the old-fashioned business of connecting human beings and machines to the internet from orbit is doing a lot of the financial heavy lifting. Starlink generated roughly 11 to 12 billion dollars of revenue in 2025, accounting for more than 60 percent of SpaceX’s total top line that year. More importantly, it posted operating profits in the neighborhood of 4.4 billion dollars, making it the company’s core profit engine even as consolidated results dipped into the red.
That profitability matters because it effectively positions Starlink as the internal banker for both the space and AI ambitions, providing recurring cash flow from subscription connectivity to offset losses elsewhere in the portfolio. For investors, the story is less about a single grand moonshot and more about a conglomerate structure where a maturing satellite telecom business subsidizes an aggressively loss-making AI and launch ecosystem.
Rockets, Reusability, and Red Ink
The more traditional space operations—launch services, Starship development, and government contracts—remain strategically central but financially more modest and, at times, loss-making. SpaceX’s space segment generated around 4.1 billion dollars of revenue in 2025, growing at a single-digit pace despite high-profile Pentagon and NASA work.
On the cost side, filings indicate heavy spending on Starship, the company’s next-generation heavy-lift system, as well as ongoing investments in reusable launch capabilities that aim to reset the economics of getting mass to orbit. Those programs, while deeply negative for current profits, are presented as foundational infrastructure for both the satellite network and future off-planet industries, from lunar logistics to Mars transport.
AI in Orbit: Why the Sky Needs Servers
The logic behind SpaceX’s AI obsession is not purely thematic: the company is effectively arguing that the next wave of AI compute will need to break free from terrestrial constraints. Space-based infrastructure, in this view, can host massive computing power at global scale, with orbital data centers and satellite backbones delivering low-latency networks that reach markets traditional cloud regions cannot.
Some projections tied to the IPO suggest that at full buildout, the AI computing power associated with SpaceX’s plans could reach hundreds of gigawatts per year, a figure that would rival the current electricity consumption of entire national economies. To skeptics, those numbers read like science fiction; to supporters, they are simply an extrapolation of the same exponential curves that defined the last two decades of cloud and semiconductor growth.
Losses Now, Optionality Later
On a consolidated basis, SpaceX reported around 18 billion dollars of revenue in 2025 and a net loss of roughly 4.9 billion dollars, even as adjusted EBITDA landed north of 6.5 billion dollars. The delta, as management is happy to point out, is largely driven by aggressive capex, stock-based compensation, and the inclusion of hefty AI losses from the xAI acquisition.
The AI segment alone recorded operating losses north of 6 billion dollars in 2025, while rocket operations also ran in the red, leaving Starlink as the principal source of operating profit. The pitch to investors is that today’s losses purchase a portfolio of long-dated options—on global connectivity, orbital AI, space logistics, and whatever new industries may emerge once launch costs fall far enough.
Testing Market Appetite for Mega-Tech
The SpaceX IPO will not arrive in a vacuum. Other marquee AI players, including OpenAI and Anthropic, are widely expected to pursue public listings over the next several quarters, each with valuations that could stretch well into the 11-digit range. Together, these offerings will test how much appetite investors still have for cash-burning growth stories at trillion-dollar price tags, especially after a decade in which “growth at any price” has cycled in and out of favor.
In that context, SpaceX’s hybrid narrative—profitable telecom, loss-making AI, capital-heavy rockets—offers a kind of stress test for the modern tech IPO template. It blends infrastructure-like cash flows with venture-style risk, asking the market to value a single security as both the next great utility and a speculative ticket on interplanetary commerce.
A Wall Street Story in Three Acts
For all the futuristic framing, the SpaceX IPO story will feel familiar to veterans of earlier waves of technological exuberance. In the first act, a transformational technology—cheap reusability in launch, global satellite internet, AI in orbit—makes previously unthinkable projects seem economically plausible. In the second, capital floods in, funding a buildout phase where capex curves go nearly vertical and the income statement plays catch-up.
The third act is the one investors are still debating: whether the world truly needs a 28.5 trillion dollar stack of AI, connectivity, and space services, and whether SpaceX is the company to deliver it while competing with both terrestrial hyperscalers and emerging AI platforms. For now, the only certainty is that when the rockets and the AI servers share the same balance sheet, the resulting prospectus makes for unusually lively reading—even by Wall Street’s increasingly cinematic standards.
The Sources
[1] SpaceX’s IPO charts reveal a company spending like an AI giant https://finance.yahoo.com/markets/article/spacexs-ipo-charts-reveal-a-company-spending-like-an-ai-giant-chart-of-the-day-120213160.html [2] 6 Charts on SpaceX’s Pre-IPO Financials – Morningstar https://www.morningstar.com/stocks/6-charts-spacexs-s-1-financials [3] SpaceX IPO will test investor appetite for big tech as AI rivals also … https://www.fefundinfo.com/insights/weekly-market-update-spacex-ipo-will-test-investor-appetite-for-big-tech-as-ai-rivals-also-prepare-to-list [4] SpaceX revenue, valuation & funding | Sacra https://sacra.com/c/spacex/ [5] SpaceX IPO: 3 Investor Flags You Shouldn’t Ignore – MarketWise https://marketwise.com/investing/spacex-ipo-3-unusual-things-musk-plan/ [6] What is Growth Strategy and Future Prospects of SpaceX Company? https://pestel-analysis.com/blogs/growth-strategy/spacex [7] SpaceX Funding and Investor Insights | Comprehensive Analysis – Exa https://exa.ai/websets/directory/spacex-funding [8] Elon Musk’s SpaceX IPO plans reveal blockbuster spending – NPR https://www.npr.org/2026/05/20/nx-s1-5812731/elon-musk-spacex-ai-ipo [9] SpaceX’s IPO charts reveal a company spending like an AI giant … https://www.facebook.com/SpaceXFP/posts/spacexs-ipo-charts-reveal-a-company-spending-like-an-ai-giant-spacex-ipo-ai-tech/1032381165976606/ [10] SpaceX’s IPO charts reveal a company spending like an AI giant https://x.com/YahooFinance/status/2058565205425103056 [11] SpaceX’s IPO charts reveal a company spending like an AI giant https://www.reddit.com/r/StockMarket/comments/1tmg54d/spacexs_ipo_charts_reveal_a_company_spending_like/ [12] SpaceX’s IPO charts reveal a company spending like an AI giant https://www.linkedin.com/posts/kayla-burrows-46a2806_spacexs-ipo-charts-reveal-a-company-spending-activity-7464388047229472768-2Q89 [13] Finance and Markets https://www.wsj.com/finance [14] How to write headlines like The Wall Street Journal – Ragan Communications | Ragan Communications and PR Daily https://www.linkedin.com/posts/ragan-communications_how-to-write-headlines-like-the-wall-street-activity-7319045828017377280-MVMv [15] SpaceX’s IPO charts reveal a company spending like an AI giant. https://www.facebook.com/SpaceXFP/photos/spacexs-ipo-charts-reveal-a-company-spending-like-an-ai-giant-spacex-ipo-ai-tech/1032381122643277/
The United States is quietly tightening its Ebola defenses, and this time Atlanta’s massive air hub and a small vaccine developer based in Atlanta named GeoVax Labs (NASDAQ: GOVX) are sharing the spotlight in a story that is more about preparedness than panic.
Atlanta Joins the Front Line
Federal health officials have added Hartsfield-Jackson Atlanta International Airport to the list of U.S. gateways conducting enhanced screening for travelers arriving from Ebola-affected parts of Central and East Africa. Returning Americans and permanent residents who have recently been in the Democratic Republic of the Congo, Uganda, or South Sudan are now funneled through designated airports—Washington Dulles first, Atlanta next—for temperature checks, health questionnaires, and updated contact information.
The Centers for Disease Control and Prevention, headquartered just a short drive from the runways in Atlanta, stresses that the immediate risk to the general U.S. public remains low even as it layers on additional safeguards. In practical terms, that means more clipboards and contact tracing, not hazmat suits in concourses—a public-health version of tightening the seatbelt long before the plane hits turbulence.
A Familiar Playbook, With More Pages
The new measures echo the playbook the U.S. used during past Ebola scares, when a small group of major airports handled the bulk of travelers from affected regions and subjected them to “enhanced entry screening.” Then, as now, the process combines exit screening in affected countries with layered checks upon arrival in the U.S., including symptom reviews, temperature checks and follow-up monitoring in coordination with state and local health departments.
What has changed is the backdrop: multiple outbreaks in Central Africa and a particular focus on Bundibugyo Ebola virus, a less-famous cousin in the filovirus family that still poses a serious threat where it circulates. The CDC, working with the Department of Homeland Security and airlines, is leaning on port-of-entry controls, expanded laboratory capacity, and hospital readiness to keep that threat overseas—a reminder that in public health, the best-case scenario is the crisis that never happens.
Bundibugyo Ebola Puts Biotech on Notice
The Bundibugyo outbreak has not only mobilized public-health agencies; it has also sharpened the focus of the biodefense and vaccine industry. Clinical-stage biotech GeoVax Labs has publicly highlighted the outbreak as a case study in why flexible vaccine platforms may matter more than strain-by-strain solutions.
GeoVax, which trades on Nasdaq under the ticker GOVX, has been developing vaccines using a modified vaccinia Ankara, or MVA, platform designed to be adapted across multiple filoviruses, including different Ebola species. Company statements emphasize the limitations of vaccines that target only one strain at a time in a world where viral families, not single variants, drive recurring outbreaks. It is the biotech equivalent of replacing a drawer full of single-use phone chargers with one universal adapter—less glamorous than a moonshot, but potentially more useful when the power suddenly goes out.
Airports, Algorithms and the Investor Lens
For airlines, like Delta Airlines (DAL) routing travelers from affected countries through a handful of airports creates operational headaches but also regulatory clarity: instead of chasing evolving advisories across the network, carriers know which hubs must be staffed and equipped for health screening. For Atlanta, already among the world’s busiest airports by passenger volume, the designation formalizes a role many in the industry had assumed it would eventually play, given the CDC’s presence and its established procedures from prior Ebola responses.
Investors, meanwhile, are parsing every headline for hints of where capital and contracts may flow next. GeoVax has already seen bursts of trading activity as its Ebola commentary intersected with broader concern about global outbreaks, even as analysts caution that meaningful revenue is more likely to come from long-term government procurement than from short-lived market anxiety. In the short run, the story is about sentiment; in the long run, it is about whether platforms like MVA become part of a standard biodefense toolkit alongside stockpiles of more traditional vaccines.
Managing Fear, Betting on Preparedness
Public-health officials are walking a familiar tightrope: doing enough to prevent imported cases without doing so much that they trigger unnecessary alarm. The CDC’s messaging has emphasized that the enhanced screening is precautionary and time-limited, with risk assessments updated as on-the-ground conditions in Africa evolve. That nuance is easy to miss in the scroll of social media, but it matters for communities near the designated airports where “Ebola screening” can sound more dramatic than the reality of thermometers, forms and follow-up phone calls.
For markets, the policy shift is another reminder that infectious disease remains a structural, not cyclical, risk—one that can upend travel, push governments toward emergency orders and create sudden spotlights on small-cap biotech names that spend most years in relative obscurity. The more optimistic reading, and the one investors in defense, healthcare and travel are increasingly pricing in, is that each outbreak nudges the system toward better surveillance, more adaptable vaccine technology and a faster, calmer response the next time a virus makes news.
Memorial Day occupies a uniquely American position in the national calendar—a solemn tribute to fallen service members that doubles as the unofficial kickoff to summer, complete with barbecues, beach trips, and retail promotions. This dual identity, far from diminishing the holiday’s significance, reflects a democratic impulse to weave remembrance into the fabric of everyday life rather than sequestering it in hushed ceremonial spaces.
From Flowers to Federal Holiday
The holiday emerged from the aftermath of the Civil War, which claimed approximately 620,000 lives—roughly 2% of the nation’s population—and necessitated the creation of America’s first national cemeteries. In the late 1860s, communities across the country spontaneously began springtime tributes, decorating soldiers’ graves with flowers and reciting prayers. One of the earliest documented observances occurred less than a month after the Confederacy’s surrender in 1865, organized by formerly enslaved people in Charleston, South Carolina, who transformed a former racetrack prison for Union captives into a proper burial ground.newsroom.
On May 5, 1868, General John A. Logan, leader of the Grand Army of the Republic—an organization of Union veterans—formalized these grassroots efforts by calling for a nationwide “Decoration Day” on May 30th. He deliberately selected a date that marked no particular battle, ensuring the observance would honor sacrifice itself rather than military victory. The federal government later designated Waterloo, New York, as the official birthplace of Memorial Day, recognizing the town’s 1866 community-wide event during which businesses closed and residents decorated graves with flowers and flags.
The Evolution of Remembrance
Initially honoring only Civil War dead, the holiday expanded after World War I to commemorate American military personnel who died in all conflicts, including World War II, Korea, Vietnam, and the wars in Iraq and Afghanistan. By 1890, all Northern states had made Decoration Day an official state holiday, though Southern states continued honoring their dead on separate days until after the First World War.
The transformation from Decoration Day to Memorial Day culminated in 1971, when Congress passed the Uniform Monday Holiday Act, establishing the observance on the last Monday of May and declaring it a federal holiday. The legislation created a three-day weekend for federal employees—a move that perhaps unintentionally accelerated the holiday’s commercial dimension while maintaining its commemorative core.
Modern Traditions and the Paradox of Memory
Today’s Memorial Day observances span a remarkable spectrum: large-scale parades in Chicago, New York, and Washington, D.C., featuring military personnel and veterans’ organizations; cemetery visits and memorial services; and the wearing of red poppies inspired by a World War I poem. At 3:00 p.m. local time each Memorial Day, a national moment of remembrance invites Americans to pause collectively.
Yet these solemn rituals coexist with weekend getaways, backyard parties, and the retail extravaganza that marks summer’s unofficial arrival. This juxtaposition might seem jarring to purists, but it embodies a distinctly American approach to civic life—one that trusts citizens to hold gratitude and leisure, reverence and recreation, in productive tension rather than rigid compartmentalization. The holiday’s enduring power lies not in choosing between remembrance and celebration, but in demonstrating that a mature democracy can honor both impulses simultaneously.
AI is quietly rewriting the music industry’s sheet music, shifting power from a handful of labels and gatekeepers toward whoever can best orchestrate data, algorithms, and rights.
A New Overture: From Gatekeepers to Code Keepers
For a century, the music business ran on a familiar score: labels financed talent, controlled distribution, and owned the catalogs, while artists hoped their royalties would eventually catch up with their tour schedules. Now, generative AI tools can spin up radio‑ready tracks in minutes, mimic iconic voices, and churn out endless variations of a hook long before a label A&R has finished their second espresso.
Industry executives are moving from outright panic to what might be called cautious optimism, recognizing that the real threat is not AI itself, but who owns and directs it. Just as streaming reordered the hierarchy from CD racks to platform playlists, AI is setting up a new contest between rights holders, tech platforms, and a growing class of AI‑native creators.
The New Power Players: Models, Catalogs and Compute
In the emerging AI‑music order, three assets matter most: data, rights, and compute. Models trained on vast libraries of recordings can now generate melodies, stems, and even full productions that sound uncannily like human‑made music, raising both creative possibilities and existential legal questions.
Major labels and publishers, once wary of “machine‑made hits,” are quietly repositioning as AI’s preferred data partners, leveraging deep catalogs as negotiating chips with model developers and platforms. Tech firms, meanwhile, control the infrastructure and algorithms that decide which tracks get surfaced, recommended, or buried—effectively becoming the new program directors of the global jukebox. In this environment, compute capacity and licensing sophistication may matter as much as a label’s historic ear for talent.
Synthetic Voices, Real Money
Perhaps the most controversial shift is the rise of synthetic vocals that can convincingly emulate star performers, living or dead. An artist’s voice, once considered a uniquely human instrument, is now a monetizable parameter—one that can be cloned, licensed, or, in the worst cases, pirated.
Legal frameworks are racing to catch up. International copyright still hinges on human authorship, meaning fully AI‑generated tracks often fall into a protection gray zone, while human‑guided AI creations may still qualify for conventional rights. Industry groups are pushing principles that keep human creativity at the center, calling for clear labelling of AI‑generated music and stronger personality rights to prevent unauthorized use of an artist’s voice or likeness. The punchline: in a world of infinite fake duets, authenticity—and enforceable contracts—may become the most valuable instruments on the balance sheet.
Artists, Algorithms and the Middle Class of Music
For working artists, AI is both a productivity tool and a competitive threat. On the one hand, creators can now separate stems, experiment with arrangements, master tracks, and even test different vocal textures with a level of speed and affordability that once required label budgets. On the other, forecasts of a “tsunami” of AI‑generated songs suggest an already crowded digital marketplace will become even more saturated, raising the bar for discovery and sustainable income.
Analysts warn that without thoughtful guardrails, AI could accelerate the erosion of the “middle class” of musicians, squeezing independents between a flood of low‑cost synthetic tracks and a small cohort of superstar brands that can afford bespoke AI tools and legal protection. Yet some see opportunity in artists who productize themselves—building owned fan communities, licensing their voice and style on their own terms, and treating AI as a studio extension rather than a rival act. The future working musician may look less like a touring purist and more like a diversified media company with a catalog, a dataset, and a personal brand.
Regulators, Rightholders and the Search for a New Deal
As AI seeps into everything from recommendation engines to rights administration, lawmakers and trade bodies are trying to sketch a new social contract for the creative economy. Jurisdictions from Japan to the EU to the U.S. are testing different approaches to training data, fair use, and opt‑out rights, with the outcome likely to determine which regions become AI‑music hubs and which remain net importers of innovation.
Industry associations are coalescing around a few core principles: protect human creators, ensure transparency when music is AI‑generated, recognize personality rights in voice and likeness, and avoid a race to the bottom where unlicensed training data becomes an accepted cost of doing business. Digital platforms, for their part, are experimenting with AI that can detect deepfake vocals and give labels and artists choices on whether to block, track, or monetize such content. If the streaming era was about who controlled the playlist, the AI era may hinge on who controls the definition of authorship itself.
The Encore: Human Intuition in a Machine Age
Despite the headlines, AI is not yet composing the end credits for human music. Rather, it is shifting the sources of leverage: from CD pressing plants to server farms, from radio promotion to recommendation algorithms, and from backroom publishing deals to explicit licensing for data and digital likeness.
In that context, artists, labels, and platforms that treat AI as an instrument—powerful, temperamental, and in need of rules—may find themselves best positioned in the next movement of the industry. The music business has survived vinyl, piracy, and streaming; its latest test is to prove that in a world of synthetic sound, human judgment still calls the tune.
The Sources
[1] The music industry’s AI stance is shifting toward cautious optimism https://www.cnbc.com/video/2026/05/21/the-music-industrys-ai-stance-is-shifting-toward-cautious-optimism.html [2] How AI is reshaping the music industry https://www.musicbusinessworldwide.com/how-ai-is-reshaping-the-music-industry/ [3] The Sound Shift: How Generative AI is Redefining the Music … https://www.artefact.com/blog/the-sound-shift-how-generative-ai-is-redefining-the-music-industrys-business-model/ [4] How AI Is Changing the Music Industry | Bloomberg Tech – YouTube https://www.youtube.com/watch?v=h4rjoItWbb8 [5] Music Industry 5 Key Principles on Artificial Intelligence https://www.ukmusic.org/research-reports/music-industry-5-key-principles-on-artificial-intelligence/ [6] AI Music: What Musicians Need to Know – Berklee Online Take Note https://online.berklee.edu/takenote/ai-music-what-musicians-need-to-know/ [7] How AI is transforming the creative economy and music industry https://www.ohio.edu/news/2024/04/how-ai-transforming-creative-economy-music-industry [8] AI Impact: How AI is transforming the music industry – YouTube https://www.youtube.com/watch?v=E1wDOAmYHSs [9] AI’s Impact On Music In 2025: Licensing, Creativity And Industry … https://www.forbes.com/sites/virginieberger/2024/12/30/ais-impact-on-music-in-2025-licensing-creativity-and-industry-survival/ [10] AI-generated music is going viral. Should the music industry worry? https://www.cnbc.com/2025/07/17/ai-generated-music-is-going-viral-should-the-music-industry-worry.html [11] What’s the future of the music industry after AI? – Reddit https://www.reddit.com/r/musicindustry/comments/1kwkm0c/whats_the_future_of_the_music_industry_after_ai/ [12] How AI will slowly destroy the music business – Facebook https://www.facebook.com/rickbeatoproduction/posts/how-ai-will-slowly-destroy-the-music-business/1323586889135256/ [13] How AI is Reshaping the Music Industry (2025) – YouTube https://www.youtube.com/watch?v=CokiSZ636sc [14] How to Write Headlines Like The Wall Street Journal https://raganconsulting.com/5-tips-to-write-headlines-from-the-wall-street-journal/ [15] Prompt Library – ChatHub https://chathub.gg/prompt-library
Older Americans are “un-retiring” in growing numbers, turning the golden years into the “gone back to the office” years—driven mostly by higher living costs, but also by a desire to stay sharp and connected. This revival of gray-collar labor is reshaping the job market, Social Security math, and even how we define retirement itself.
The New American Pastime: Un-Retiring
Retirement used to be a one-way exit—cake, speeches, and a permanent handoff of the office keycard. Now, for a meaningful slice of older Americans, it looks more like a round-trip ticket. Recent data show that around 6–7% of retirees have reentered the labor force in just the past several months, with millions more either working beyond 65 or considering a return.
Behind the numbers is a simple story: life got more expensive, and retirement savings did not keep pace. As inflation and housing, health care, and everyday expenses rose in recent years, more retirees discovered that “fixed income” sometimes means “fixed, but not quite enough.”
When “Fixed Income” Meets Flexible Work
Survey after survey points to a common motive: money. An AARP study finds that nearly half of older adults who have gone back to work say the primary reason is to earn more income, with basic living costs topping the list. Among people 50 and older who are working or job hunting, roughly four in ten say they’re doing so mainly to cover everyday expenses, not luxuries.
Social Security offers a baseline, but it rarely feels like a finish line. About half of older Americans receive less than roughly $20,500 a year in Social Security benefits, and median retiree income sits under $30,000—numbers that can look thin against modern rent, groceries, and medical bills. For many, the most realistic “yield-enhancement strategy” is the oldest one in the book: go back to work.
The Silver Labor Force Steps Back In
The once-narrow trickle of post-retirement workers has become a meaningful share of the labor market. Nearly one in five adults aged 65 and older is now working or looking for work, the highest level in decades, and older workers are the only age group with a rising labor-force participation rate. In some studies, as many as 20–25% of retirees are working part- or full-time by their late 60s or 70s, with several more percent actively searching.
Economists have long noted that retirement is not always a one-and-done decision. Longitudinal research suggests that a significant minority of retirees follow “nontraditional” paths, leaving full-time careers, then reentering the labor market as part-time employees, consultants, or even small-business owners. In other words, the corporate farewell party may be less a finale and more an intermission.
Inflation, Longevity, and the Math of “Enough”
Un-retirement is not happening in a vacuum; it is happening in an era of longer lifespans, volatile markets, and persistent inflation. Many retirees planned for a 20-year stretch; the actuarial tables increasingly suggest a 30-year horizon—and that extra decade has to be funded somehow.
Compounding the pressure, a meaningful share of older Americans reaches retirement with limited or no savings. One survey finds that about 18% of people 50 and older have nothing set aside for retirement, while others are watching their modest nest eggs eroded by higher prices. When portfolio withdrawals collide with rising costs, going back to work can feel less like a lifestyle choice and more like a line item in the household budget.
Beyond the Paycheck: Purpose, Brains, and Boredom
The story, however, is not all about financial strain. A notable slice of older workers say they are returning to the job market because they like what they do, want to stay active, or simply miss the daily rhythm of work. Studies of older adults show strong nonfinancial motives: enjoying their work, staying mentally alert, maintaining a sense of purpose, and keeping social connections alive.
In one survey of older adults who continue working, more than 40% cite enjoyment or staying active as key reasons, with many highlighting the role of work in keeping their brains engaged. For these un-retirees, the new job description might read: will work for stimulus, camaraderie, and a little extra income on the side.
Flexible Schedules and Second Acts
Today’s un-retirees are not necessarily lining up for 40-hour weeks under fluorescent lights. Many say they would be eager to return to work if they could secure flexible schedules, part-time roles, or hybrid arrangements that accommodate health needs and family responsibilities.
Surveys suggest that a sizable minority of retirees are either open to or actively looking for work, with flexibility as a key condition. Options range from consulting and gig work to customer-service roles, professional services, and small-business ventures, often without traditional benefits but with more control over time. It is the semi-retired portfolio career: a bit of income, a bit of stimulation, and ideally, no commute longer than one podcast.
Employers Discover the Value of Experience
For employers, this gray wave represents both a challenge and an opportunity. Older workers bring decades of institutional knowledge, soft skills, and professional networks, at a moment when many industries face labor shortages and demographic shifts. Public workforce programs are already serving more workers age 50 and over, reflecting their growing share among job seekers.
The friction lies in hiring practices and perceptions. Many retirees worry that their age will be a barrier, and some are not wrong: surveys show a significant portion expect age to make job hunting harder, even as employers publicly tout their interest in experience. The labor market is still learning how to price wisdom.
Redefining Retirement in Real Time
Put together, the data suggest that retirement in America is moving from a destination to a phase—one that can include encore careers, part-time stints, and periodic returns to the labor market. By late 2024, estimates indicated that as many as a quarter of retirees were working in some form, with additional retirees actively seeking jobs.
That shift carries implications for policymakers as well as households. As older Americans work longer, questions about Social Security, labor protections, retraining programs, and age discrimination become more central, not less. At the kitchen-table level, financial planning increasingly means modeling not just “When can I retire?” but “When might I un-retire—and on what terms?”
If the old goal was to stop working as soon as possible, the emerging model is more nuanced: work longer, pause, pivot, then work differently. For a growing number of older Americans, retirement is less like closing the book and more like turning the page to a new chapter—one that, at least for now, still comes with a timesheet.
The Sources
[1] Considering un-retirement? More older Americans are rejoining the … https://finance.yahoo.com/economy/article/considering-un-retirement-more-older-americans-are-rejoining-the-workforce-often-out-of-financial-need-120341567.html [2] Retirement on Pause: High Costs Push Older Americans Back to Work https://www.aarp.org/press/releases/2026-02-05-high-costs-older-americans-back-to-work.html [3] More U.S. Residents Are Working Past Retirement Age https://www.pew.org/en/research-and-analysis/articles/2025/08/04/more-us-residents-are-working-past-retirement-age [4] The Aging of America: A Changing Picture of Work and Retirement https://cri.georgetown.edu/the-aging-of-america-a-changing-picture-of-work-and-retirement/ [5] Improving workforce programs for older workers | Research Highlights https://www.upjohn.org/research-highlights/improving-workforce-programs-older-workers [6] For some older Americans, retirement today means unretiring https://www.cbsnews.com/news/retirement-older-americans-going-back-to-work/ [7] [PDF] Reentering the labor force after retirement https://www.bls.gov/opub/mlr/2011/06/art2full.pdf [8] Older Adults Are Returning to Work https://www.councilonaging.org/blog/older-adults-returning-to-work/ [9] Americans are leaving retirement and heading back to work. New … https://www.facebook.com/NewsOn6/posts/more-americans-are-leaving-retirement-and-heading-back-to-worknew-research-from-/1317542656860468/ [10] From Retired to Rehired: The Rise of ‘Unretirement’ in America https://www.ncsl.org/resources/details/from-retired-to-rehired-the-rise-of-unretirement-in-america [11] Back to Work: Expectations and Realizations of Work after Retirement https://pmc.ncbi.nlm.nih.gov/articles/PMC4004604/ [12] Nearly a third of retirees want to rejoin the workforce – LinkedIn https://www.linkedin.com/pulse/nearly-third-retirees-want-rejoin-workforce-other-world-taylor-borden [13] People return to work for many reasons, but the biggest is financial … https://www.facebook.com/nytimes/posts/people-return-to-work-for-many-reasons-but-the-biggest-is-financial-need-as-cost/1366211435361316/ [14] Finance and Markets https://www.wsj.com/finance [15] Prompt Library – ChatHub https://chathub.gg/prompt-library
InterGroup Corporation’s (INTG) quarter now reads like a micro‑chapter in San Francisco’s broader comeback, where hotel lobbies, balance sheets, and city policy are finally pulling in the same direction. Some investors have been noticing this transformation as the INTG’s stock is now up approximately 257.06% over the last year.
InterGroup’s Quarter: A Small-Cap With Big-City Momentum
The InterGroup Corporation, the small‑cap landlord and hotelier behind one of San Francisco’s better‑known Financial District hotels (Hilton San Francisco Financial District, a 558-room hotel located 750 Kearny St., San Francisco, California 94108), just posted a quarter that feels far more “urban renewal” than “doom loop.” Revenue climbed to roughly 20.4 million dollars, up approximately 21% year over year, and net income flipped from a loss to a solid profit as the company leaned into a citywide resurgence fueled by artificial intelligence, real estate leasing, and rebounding tourism.
For a business long tethered to the fortunes of San Francisco’s downtown, the numbers matter as much for what they say about the city as they do about the stock. InterGroup’s lobby is becoming a front‑row seat to a broader urban recovery—one where cash‑paying guests, not just AI models, are back to checking in.
AI Wealth Meets Real Lobby Traffic
InterGroup’s growth story this quarter was written largely at the front desk. Hotel revenues surged—up roughly a third from a year earlier—as business travel, events and tourism continued to seep back into downtown San Francisco. Management pointed to improved hotel metrics as the main engine of the top‑line acceleration, with room rates and occupancy finally looking more like a business hub than a ghost town.
Real estate income, by contrast, edged lower, a reminder that multi‑family and commercial properties are still digesting higher rates and post‑pandemic usage shifts. Yet the hotel momentum more than offset that drag, leaving total revenue comfortably ahead of last year and above the levels investors had grown accustomed to when headlines about San Francisco skewed more dystopian than destination‑worthy.
Real Estate and Leasing: Office Lights Back On
Beyond the hotel, San Francisco’s broader real estate story is shifting from “for lease” signs to signed leases. Even as overall commercial vacancy remains a structural challenge, office leasing volumes have reached multi‑year highs, and key innovation corridors are seeing tangible tightening in space availability. That renewed tenant demand lifts the backdrop for InterGroup’s mixed portfolio of hospitality and real estate assets, offering a more supportive environment than the one it faced at the depths of the pandemic.
Residential real estate is also participating in the rebound, with single‑family homes frequently selling above asking prices as buyers front‑run anticipated tech IPOs and liquidity events. In practical terms, that means the city’s professional class has more reason—and more means—to stay, work, and host clients in San Francisco, a subtle but important tailwind for hotel occupancy and rates.
Downtown, Retail, and Union Square’s Second Act
The narrative around downtown San Francisco and Union Square is no longer just about boarded‑up storefronts and social media hot takes. New flagship locations and local brand openings—from global entertainment names to high‑end resale concepts—are reshaping the retail landscape and drawing both locals and tourists back into the core. That foot traffic supports the restaurants, bars, and attractions that hotel guests expect within walking distance, turning an overnight stay into a broader urban experience.
For InterGroup, a more animated downtown means its hotel operates as a gateway, not a cul‑de‑sac. When Union Square adds new anchors and neighborhood streets regain their buzz, room nights and rate integrity become easier to defend, particularly with business travelers and higher‑spend visitors.
Tourism, Events, and a $9 Billion Windfall
Tourism is once again doing its part to keep San Francisco’s economy humming. Millions of visitors are expected to generate more than 9 billion dollars in local spending in 2026, as conventions, leisure travel, and marquee events crowd the calendar. High‑profile sporting and endurance events—including iconic draws like the Escape from Alcatraz Triathlon—help fill hotels, restaurants, and waterfront promenades, creating a reliable pipeline of visitors who see the city as a destination rather than a headline.
InterGroup’s hotel sits squarely in that flow. Each returning conference, sports weekend, or tourist surge translates into room demand and ancillary revenue, reinforcing the company’s latest quarter as something more durable than a one‑off uptick.
City Hall’s Role: Fewer Forms, Faster Projects
The policy side of the comeback is being shaped in no small part by City Hall. Mayor Daniel Lurie has launched initiatives such as PermitSF, an effort aimed at consolidating the city’s notoriously fragmented permitting process, cutting bureaucratic lag, and speeding up housing and development approvals. For developers, landlords, and hotel owners alike, faster approvals can be the difference between “someday” projects and actual cranes in the sky.
InterGroup may not be a mega‑developer, but it operates at the intersection of these reforms, particularly as the city nudges new housing and mixed‑use projects into motion. A more predictable permitting environment supports reinvestment in existing properties and makes future capital allocation decisions slightly less like a regulatory obstacle course.
The Quarter by the Numbers: Lobby Cash Flow vs. Hype
Against this citywide backdrop, InterGroup’s financials look less like a speculation story and more like a cash‑flow‑in‑progress. The company’s hotel segment again drove a sizable portion of the roughly 21% revenue growth, supported by higher occupancy and improved rate dynamics as business and leisure demand returned. Operating income improved meaningfully and net income turned positive, signaling that the lobby’s revenue cadence is finally outrunning the noise from broader tech and market narratives.
Real estate income was more subdued, reflecting ongoing adjustments in its multi-sates multi‑family and commercial markets amid elevated interest rates and shifting office usage patterns. Yet, taken together, the hotel and property portfolio delivered enough momentum to re‑anchor the income statement, shifting the storyline from “survival mode” to “measured recovery.”
A Small-Cap Story in a Big-Tech Town & Beyond
INTG’s ticker may not trend on social media, but that might be exactly what appeals to its shareholder base. The company’s modest market capitalization, limited, but significantly improving trading volume, and hybrid portfolio of hospitality and real estate assets make it an idiosyncratic holding in a market dominated by mega‑cap AI names and quant‑friendly narratives. For investors willing to look beyond the usual suspects, InterGroup represents a leverage point on San Francisco’s physical economy rather than just its digital one.
The Sources
The InterGroup Corporation – Official site https://www.intgla.comintgla
The InterGroup Corporation – Press release: Third Quarter Fiscal 2026 Results (filed with SEC) https://www.sec.gov/Archives/edgar/data/69422/000149315226022253/ex99-1.htmsec
The InterGroup Corporation (INTG) – Income statement and financials https://finance.yahoo.com/quote/INTG/financials/finance.yahoo
InterGroup Corporation – Financial summary and recent quarterly trends https://www.investing.com/equities/the-intergroup-co-financial-summaryinvesting
InterGroup Corporation – Annual reports and filings archive https://www.annualreports.com/Company/the-intergroup-corporationannualreports
InterGroup Corporation (INTG) – Fundamental data overview https://data.intrinio.com/company/INTG?type=category&category=micro-cap&category_name=Micro+Cap&query=data.intrinio
San Francisco Multifamily Market Report – 2026 Investment Forecast (Marcus & Millichap) https://www.marcusmillichap.com/research/market-report/san-francisco/san-francisco-2026-investment-forecast-multifamily-market-reportmarcusmillichap
San Francisco Real Estate – January 2026 Market Report (The Lurie Group) https://luriegroup.com/blog/san-francisco-2026-january-real-estate-reportluriegroup
San Francisco Bay Area Tech & AI Talent Surge (CBRE Scoring Tech Talent report coverage) https://www.cbre.com/press-releases/san-francisco-bay-area-sees-surge-in-tech-talent-with-ai-skills-fueling-next-tech-growth-cyclecbre
AI’s Role in San Francisco’s Tech Future – Overview of AI and data science ecosystem https://www.immerse.education/career-exploration/software-engineering/how-san-francisco-is-shaping-tech-future/immerse
AI Funding and Office Vacancy Trends in San Francisco https://www.mindspace.me/blog/ai-impact-on-san-francisco-office-vacancy/mindspace
U.S. Real Estate Markets to Watch 2026 – San Francisco outlook (PwC Emerging Trends) https://www.pwc.com/us/en/industries/financial-services/asset-wealth-management/real-estate/emerging-trends-in-real-estate-pwc-us.htmlpwc
Mayor Daniel Lurie – PermitSF Legislation and Downtown Revitalization Measures https://www.sf.gov/news-mayor-lurie-signs-permitsf-legislation-cutting-red-tape-for-small-businesses-driving-economic-recoverysf
Coverage of PermitSF and City Hall permit‑reform debates (local reporting) https://www.sfchronicle.com/sf/article/opengov-permitsf-permit-san-francisco-22257828.phpsfchronicle
The week ending Friday, May 22, 2026, saw U.S. equities grind higher into the Memorial Day weekend, with the S&P 500 extending its longest weekly winning streak since 2023 and the Dow Jones Industrial Average tagging fresh record highs as investors leaned into AI, resilient consumer demand, and hopes that geopolitical and inflation risks can be managed rather than avoided. Beneath the surface, however, rising oil prices, still‑elevated Treasury yields, and quiet but important debate over the Federal Reserve’s “plumbing” signaled that the late‑cycle backdrop remains complex even as risk assets continue to climb.
Index performance and market tone
Major U.S. indexes finished the week higher, with the S&P 500 moving toward the 7,450–7,500 area and on track for an eighth straight week of gains and closing at 7,43.47 marking its longest weekly win streak since late 2023. The Dow Jones Industrial Average notched a record closing high and an intraday high late in the week, closing at 50,579.70 helped by a broad bid for blue chips into the holiday weekend, while the Nasdaq Composite also advanced, albeit more modestly as some mega‑cap AI leaders paused after strong prior gains.
Trading remained relatively orderly: early‑week pressure from higher yields and expensive energy moderated as oil backed off its highs and long‑term yields eased from peak levels, allowing equities to stabilize and buyers to re‑emerge. Volatility stayed subdued, with measures such as the VIX hovering near levels seen earlier in the year closing at $16.70 and off 6.29% over the last 5-days, consistent with a market that is climbing a wall of worry rather than reacting to single headlines.
Sector moves and leadership
Leadership continued to cluster around technology and AI‑linked themes, with enthusiasm for artificial intelligence infrastructure and devices remaining a defining feature of the tape. Outside of tech, energy and select defensive sectors held up relatively well against the backdrop of higher oil prices and lingering macro uncertainty, while more cyclically sensitive groups like materials and some industrials saw more mixed performance as investors weighed slower global growth forecasts against still‑solid U.S. demand.
The market’s breadth story was nuanced: investors showed willingness to pay up for clear earnings visibility and AI leverage, yet pockets of the market tied closely to rates and global trade remained choppier. This dynamic kept factor leadership tilted toward quality balance sheets and secular growth, rather than a wholesale rotation into deep cyclicals or early‑cycle value.
Macro data and Fed expectations
On the macro front, markets continued to digest an inflation picture complicated by higher‑for‑longer energy prices and still‑firm core readings. Recent CPI and PPI reports for April came in above expectations, underscoring that disinflation progress has become bumpier and feeding concerns that the Fed may need to remain restrictive for longer or even consider further tightening if price pressures re‑accelerate. At the same time, global forecasters trimmed growth expectations for 2026, with one prominent outlook now seeing world real GDP around 2.2% versus nearly 3% earlier this year, reinforcing the sense of a slower but not collapsing expansion.
In rates, the 10‑year Treasury yield pushed toward the mid‑4% area—around 4.5%–4.6%—before easing slightly late in the week as oil retreated back below $100/bbl and risk appetite improved, while the stronger dollar and weaker gold prices reflected confidence in U.S. assets despite higher funding costs. Debate intensified around the Fed’s eventual path: investors are now more focused on balance‑sheet policy, reserve levels, and the “plumbing” of money markets as potential catalysts for a regime shift, not just the timing of the next rate move.
Oil, geopolitics, and global currents
Energy remained a key swing factor for sentiment, with Brent crude holding above the 100‑dollar threshold at points and West Texas Intermediate near the high‑90s before slipping back as reports suggested tentative progress in negotiations around the Iran conflict and shipping flows. The tug‑of‑war between fears over a prolonged Middle East stalemate and periodic headlines hinting at de‑escalation produced intraday volatility in both oil and equities, though by week’s end risk assets appeared more willing to look past near‑term noise.
Globally, equity markets in Europe and Asia largely took their cues from Wall Street, with rallies in AI‑linked names and exporters offsetting concerns about weaker growth and currency volatility, including renewed focus on the yen as it drifted toward levels that have previously triggered official intervention. For U.S. investors, the story remained one of domestic strength against a more challenging international backdrop, supporting the recent outperformance of U.S. benchmarks.
Micro stories: AI devices and corporate moves
On the micro side, AI continued to drive idiosyncratic winners, including chipmakers and semiconductor ecosystem companies that benefit from the build‑out of AI computing and, increasingly, AI‑enabled end devices. Strong reactions to earnings updates and product commentary in this space underscored that investors are broadening their focus from data center demand to the next wave of AI PCs, smartphones, and edge devices, rewarding firms with credible roadmaps and tight integration with leading platforms.
Big picture for investors
Stepping back, this week’s action fit the pattern of a late‑cycle bull market that is still intact but increasingly sensitive to macro undercurrents: growth expectations are edging down, inflation risks are proving sticky, and policy plumbing issues are moving from obscure to mainstream discussions. Yet as long as earnings from AI beneficiaries, consumer‑facing firms, and high‑quality cyclicals hold up, markets seem inclined to lean into risk on pullbacks rather than abandon the rally altogether.
VP Watchlist Updates
Below is an update‑style snapshot on the VP Watchlist names for the week, focused on recent catalysts, positioning, and narrative rather than precise price moves.
Rigetti Computing, Inc. (RGTI, $26.42, +48.01% over the asteroid 5-days)
Astera Labs, Inc. (ALAB, $306.88, +31.89% over the last 5-days)
Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced preliminary financial results for the first quarter of fiscal year of 2026, ended March 31, 2026.
Amwell® (AMWL, $7.96, +5.15% over the last 5-days)
Amwell announced (May 5) financial results for the first quarter ended Mar. 31, 2026. “Entering 2026, Amwell’s main focus was to consolidate our platform to fulfill the unmet needs of our Payer and Provider customers. The Technology-Enabled Care infrastructure we have developed to fill that gap in the market continues to gain traction as customers recognize its clear advantages: lower costs, better outcomes, stronger market share and an increased level of control and agility. Our platform is performing well and built to leverage the latest AI-powered innovations, positioning it as essential infrastructure for tech-enabled care delivery,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell. “We are seeing powerful validation of the platform with significant pipeline growth and a number of meaningful renewals. With this momentum and the favorable regulatory tailwinds, Amwell is well-positioned for continued strong execution this year and to reach our goal of positive cash flow from operations in the fourth quarter.”
Eupraxia Pharmaceuticals (EPRX, $7.10, +2.31% over the last 5-days)
Eupraxia Pharmaceuticals Inc. (EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”
Eurpraxia announced on Friday, May 1, the appointment of Dr. Jeymi Tambiah as Chief Medical Officer (CMO) as well as the retirement of Dr. Mark Kowalski, Eupraxia’s current CMO. Dr. Jeymi Tambiah (MB ChB, FRCS, MS, FAPCR, FFPM), is a Board Certified Cardiothoracic Surgeon physician scientist who practiced at Guys and St Thomas’ Hospitals prior to entering the biopharmaceutical industry in 2008. Dr. Tambiah brings over 18 years of experience in clinical development, medical and regulatory strategy, and product commercialization across pharmaceutical and biotechnology organizations.
Eupraxia recently co-hosted a Tribe Public www.TribePublic.com, CEO Presentation & Q&A Webinar event, Wednesday, April 1 titled “Turning EOE Into a Once-a-Year Appointment.” The event featured James A. Helliwell, M.D., Co‑founder and CEO of Eupraxia Pharmaceuticals (NASDAQ: EPRX), who discusses the company’s precision drug‑delivery platform, its approach to Eosinophilic Esophagitis (EoE), and broader pipeline priorities, followed by a focused 5–10 minute Q&A. You may watch it now at this Youtube link.
Modular Medical (MODD, $4.34, +28.78% over the last 5-days)
Modular Medical, Inc. (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, saw (May 1) CEO Jeb Besser join Tribe Public’s members to unpack a simple question with big implications: what happens when an “almost‑pumper” market finally meets an FDA‑cleared device built for the rest of us, not just the superusers? Tribe Public hosted its CEO Presentation and Q&A Webinar, “From FDA Wins to Scaling Manufacturing – What Investors Should Watch,” on Friday, May 1, 2026, at 8:00 a.m. PT / 11:00 a.m. ET. In keeping with Tribe’s reputation for efficient programming, the session ran approximately 30 minutes, pairing a focused prepared talk with a 5–10 minute live Q&A segment that allowed investors to drill into timelines, capital needs, and commercial strategy. Besser’s formal remarks were framed under the title “From FDA Wins to Scaling Manufacturing – What Investors Should Watch,” setting the tone for a discussion that sat at the intersection of regulation, innovation, and recurring‑revenue hardware. By registering, attendees also joined Tribe Public’s membership base, ensuring they will receive future invitations to CEO briefings, sector spotlights, and investor wish‑list events.
Modular Medical announced (APRIL 19) the pricing of a registered direct offering consisting of 750,000 shares of the Company’s common stock at an offering price of $4.50 per share. The gross proceeds to the Company from the Offering are estimated to be approximately $3.4 million before deducting placement agent fees and other offering expenses. The Offering is expected to close on or about April 21, 2026, subject to the satisfaction of customary closing conditions.
Modular Medical’s latest regulatory milestone upgrades the narrative: the company has now (April 9) secured FDA 510(k) clearance for its Pivot tubeless insulin patch pump, moving from “launch‑ready” to “launch‑approved” in the heart of the fast‑growing diabesity market. The FDA has cleared Modular Medical’s Pivot patch pump as a tubeless, removable insulin delivery system, formally validating the device’s design and performance for commercial use in U.S. adults living with diabetes. The clearance converts what had been a Q1 2026 launch “subject to FDA response” into a tangible commercial pathway, giving the company permission to sell into an insulin pump market that has been estimated at roughly 8 billion dollars globally. Pivot is engineered as a simplified, two‑part patch pump with a 3‑milliliter removable reservoir, no need for battery recharging, and the ability to bolus without a dedicated controller, aiming squarely at patients who have stayed on multiple daily injections because traditional pumps felt too complex, cumbersome, or costly. By clearing Pivot, the FDA is effectively endorsing Modular Medical’s attempt to make advanced insulin delivery feel less like adopting a gadget and more like upgrading a daily habit.
The InterGroup Corporation (INTG, $41.49, +13.61% over the last 5-days)
The InterGroup Corporation (NASDAQ: INTG) announced financial (May 11) results for the fiscal third quarter ended March 31, 2026. InterGroup is a diversified holding company with interests in hospitality (through its majority‑owned subsidiary Portsmouth Square, Inc.), real estate operations, and investment transactions. The discussion below is derived from the Company’s Quarterly Report on Form 10‑Q for the quarter ended March 31, 2026. Third Quarter Fiscal 2026 Highlights (Three Months Ended March 31, 2026 vs. 2025) are as follows:
Total revenues increased to $20.372 million from $16.824 million (+21%).
Income from operations increased to $4.260 million from $2.350 million (+81%).
GAAP net income was $0.595 million, compared to a GAAP net loss of $0.750 million in the prior‑year quarter.
Net income attributable to InterGroup was $0.457 million, or $0.21 per diluted share, compared to a net loss attributable to InterGroup of $0.578 million, or $0.27 per share, in the prior‑year quarter.
Hotel revenues increased to $16.497 million from $12.210 million (+35%). For additional context, Hotel revenues for the quarter ended March 31, 2026 exceeded the comparable pre‑pandemic quarter ended March 31, 2019 by approximately $1.028 million.
Real estate revenues were $3.875 million compared to $4.614 million in the prior‑year quarter (‑16%).
Net loss from investment transactions was $(0.342) million compared to $(1.379) million in the prior‑year quarter.
Volato Group, Inc. (SOAR, +7.41% over the last 5-days) & M2i Global, Inc. (MTWO)
Nokia has quietly stitched together a new chapter in its comeback story—one that runs from American living rooms to Pentagon test ranges, and now straight through NVIDIA’s (NVDA) data centers. With NVIDIA’s billion‑dollar vote of confidence in the fall and another blockbuster NVIDIA earnings report due today, the old handset icon is suddenly speaking fluent AI.
Nokia announced (May 21) the launch of its AI Networking Innovation Lab, a new center designed to drive co-innovation with AI and cloud partners and accelerate the development of next-generation networking technologies for artificial intelligence (AI) infrastructure. Located within Nokia’s Sunnyvale, California facility, the lab serves as an innovation hub where Nokia will work across advanced AI networking technologies, architectures and ecosystems with a variety of partners to help shape the future of data center networking. AI workloads are fundamentally changing how data center networks must operate. The performance, scale, and precision required to support large-scale AI training and distributed, real-time inference place unprecedented demands on networking infrastructure. To address these challenges, Nokia is adopting a new approach to how technologies are integrated, tested, and deployed from the ground up for the AI era.
NVIDIA (NVDA, $215.33)
Nvidia’s First Quarter Fiscal 2027 earnings report crossed the tape Wednesday, May 20, and the immediate takeaway is that the AI engine is still running at full throttle, even if Wall Street was already leaning hard on the accelerator. The story today is less about whether Nvidia is growing and more about just how far into “infrastructure of AI” territory it has now ventured.
McDonald’s (MCD, $282.27, +2.13% over the last 5-days)
Morgan Stanley (April 21) has adjusted its price target on McDonald’s (MCD) to $334, maintaining an Equal Weight stance on the stock. The firm’s analyst highlighted consumer strength heading into first-quarter results, noting that earnings quality will likely vary across the restaurant and food distribution landscape . While some operators may face headwinds, the underlying consumer backdrop remains robust, which could support McDonald’s performance as one of the industry’s quality players positioned to navigate the current environment .
Tesla (TSLA, $426.01, +.89% over the last 5-days)
Tesla’s Q1 2026 performance underscored strong revenue growth and signs of margin stabilization, supported by continued investment in solar and AI initiatives. The narrative is further bolstered by Tesla’s stake in SpaceX, with anticipation building around a potential SpaceX IPO that could unlock additional shareholder value soon. However, elevated capital expenditure levels remain a key overhang, tempering investor enthusiasm despite these strategic advantages.
Serina Therapeutics (NYSE: SER, $1.98, +20.73% over the last 5-days)
Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, reported (May 14) its financial results for the first quarter ended March 31, 2026, along with key business updates. The company highlighted the follow: Phase 1b Registrational Clinical Study of SER-252 Underway in Advanced Parkinson’s Disease; TFL data from the SAD study arm targeted for first half of 2027 & Closed $21.2 million private placement financing to support continued advancement of SER-252. “With our Phase 1b registrational study of SER-252 now underway and a strengthened balance sheet, Serina is entering an important execution phase as we work toward our first clinical data in patients with advanced Parkinson’s disease,” said Steve Ledger, Chief Executive Officer of Serina. “SER-252 represents the first clinical validation of our POZ Platform™, which is designed to optimize well-understood therapeutics by improving pharmacokinetics, tolerability and dosing profiles. We believe this approach has the potential to unlock meaningful value across multiple modalities, and we are building a pipeline and partnership strategy to fully leverage the breadth of the platform.”
BuzzFeed, Inc. (BZFD, $2.09, +40.27% over the last 5-days)
FMC Corporation (NYSE:FMC) reported (April 29) first quarter 2026 results above guidance with Adjusted EBITDA above high end of range, reaffirms full-year outlook. Their first quarter 2026 revenue of $759 million, down 4 percent versus first quarter 2025. First quarter 2026 revenue, excluding India, was $762 million, down 4 percent versus first quarter 2025, which included India. On a GAAP basis, the company reported a loss of $2.25 per diluted share in the first quarter, a decrease of $2.13 versus first quarter 2025. First quarter adjusted loss per diluted share of $0.23 was down 41 cents versus first quarter 2025. FMC Corporation also announced today that its board of directors declared a regular quarterly dividend of 8 cents per share (roughly 2.26%), payable on July 16, 2026, to shareholders of record as of the close of business on June 30, 2026.
GeoVax Labs, Inc. (GOVX, $3.64, +195.93% over the last 5-days)
S&P Global – “Global Economic Outlook: May 2026” https://www.spglobal.com/market-intelligence/en/news-insights/research/2026/05/global-economic-outlook-may-2026spglobal
The Conference Board – “The Conference Board Economic Forecast for the U.S. Economy” https://www.conference-board.org/research/us-forecastconference-board
Finsyn – “Weekly Market Recap | May 22, 2026” https://www.finsyn.com/weekly-market-recap-may-22-2026/finsyn
